- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 197.85M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.58B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $5.34B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.38B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $525.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $12.4B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $12.47B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.29B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.45B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.78B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.89B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.59B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.67B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $22.18B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $21.37B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 206.2M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $113.6M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $49.4M |
| Capex | Q1 2025 · Mar 31, 2024 | $55.1M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $228M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.84 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.84 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $736.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $172.4M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $265.9M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $512.3M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.89B |